Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 62, Issue 5, 492-499
Copyright © 2005 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, K. K.
Right arrow Articles by Miller, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, K. K.
Right arrow Articles by Miller, L. M.

Reports

Update on the pharmacist shortage: National and state data through 2003

Katherine K. Knapp, Ryan M. Quist, Surrey M. Walton and Laura M. Miller

KATHERINE K. KNAPP, PH.D., is Dean, College of Pharmacy, Touro University—California, Vallejo; when this project was conducted, she was Professor and Director, Center for Pharmacy Practice Research and Development, College of Pharmacy, Western University of Health Sciences (WUHS), Pomona, CA. RYAN M. QUIST, PH.D., is Research Associate, College of Pharmacy, WUHS. SURREY M. WALTON, PH.D., is Assistant Professor of Pharmacy Administration, College of Pharmacy, University of Illinois at Chicago, Chicago. LAURA M. MILLER, PH.D., is Senior Economist, National Association of Chain Drug Stores, Alexandria, VA.

Address correspondence to Dr. Knapp at the College of Pharmacy, Touro University—California, 1310 Johnson Lane, Mare Island, Vallejo, CA 94592.


Purpose. Aggregate Demand Index (ADI) survey results were used to describe the severity of the pharmacist shortage at the national and state levels and by practice site and impact on the U.S. population.

Methods. Time-series analysis was used to characterize national and state trends in the ADI from September 1999 through September 2003. The time trends for the distribution of ratings and the demand index by practice site were also examined. Historical data about retail prescriptions filled and related growth rates were compiled and compared. ADI survey results were also compared with data from other surveys.

Results. Over time, ADI data demonstrated a continuing national pharmacist shortage, as the ability to fill pharmacist vacancies was rated at least moderately difficult. A very slight downward trend in severity (slope = –0.008) was observed. Other survey series had similar findings. States with the most severe shortage levels tended to have large populations, while those with the lowest levels tended to have smaller populations. More states improved than worsened the severity of their shortage, with 30 states maintaining the same ADI rating. Although there was a high correlation between the retail prescription growth rate and the ADI (r = 0.84), there was a much greater decrease in prescription growth (73%) than ADI levels (6.5%).

Conclusion. There was a sustained unmet demand for pharmacists throughout the United States from September 1999 through September 2003. More states moved toward having an adequate supply of pharmacists than toward having a more severe shortage of pharmacists, but the national ADI suggests that the system remains stressed.

Index terms: Data collection; Employment; Manpower; Pharmacists; Prescriptions; United States

 



This article has been cited by other articles:


Home page
J Health Serv Res PolicyHome page
K. Hassell, L. Nichols, and P. Noyce
Part of a global workforce: migration of British-trained pharmacists
J Health Serv Res Policy, April 1, 2008; 13(suppl_2): 32 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
ASHP Statement on Professionalism
Am. J. Health Syst. Pharm., January 15, 2008; 65(2): 172 - 174.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. C. Vermeulen, S. S. Rough, T. S. Thielke, R. R. Shane, M. F. Ivey, B. W. Woodward, P. G. Pierpaoli, S. M. Thomley, C. A. Borr, and D. A. Zilz
Strategic approach for improving the medication-use process in health systems: The high-performance pharmacy practice framework
Am. J. Health Syst. Pharm., August 15, 2007; 64(16): 1699 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
A. D. Tice, R. S. Turpin, C. T. Hoey, B. A. Lipsky, J. Wu, and M. A. Abramson
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections
Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1080 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
C. A. Pedersen, P. J. Schneider, and D. J. Scheckelhoff
ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2006
Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 507 - 520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society of Health-System Pharmacists.
Advertisement